Characterization of<i>Salmonella enterica</i>Serotype Newport Isolated from Humans and Food Animals
-
- S. Zhao
- Division of Animal and Food Microbiology, Office of Research, Center for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, Maryland 20708
-
- S. Qaiyumi
- Division of Animal and Food Microbiology, Office of Research, Center for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, Maryland 20708
-
- S. Friedman
- Division of Animal and Food Microbiology, Office of Research, Center for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, Maryland 20708
-
- R. Singh
- Division of Animal and Food Microbiology, Office of Research, Center for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, Maryland 20708
-
- S. L. Foley
- Division of Animal and Food Microbiology, Office of Research, Center for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, Maryland 20708
-
- D. G. White
- Division of Animal and Food Microbiology, Office of Research, Center for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, Maryland 20708
-
- P. F. McDermott
- Division of Animal and Food Microbiology, Office of Research, Center for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, Maryland 20708
-
- T. Donkar
- Division of Microbiological Studies, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland 20740
-
- C. Bolin
- Animal Health Diagnostic Laboratory, Michigan State University, East Lansing, Michigan 48824
-
- S. Munro
- Stanford University Medical Center, Stanford, California 94305
-
- E. J. Baron
- Stanford University Medical Center, Stanford, California 94305
-
- R. D. Walker
- Division of Animal and Food Microbiology, Office of Research, Center for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, Maryland 20708
抄録
<jats:title>ABSTRACT</jats:title><jats:p><jats:italic>Salmonella enterica</jats:italic>serotype Newport isolates resistant to at least nine antimicrobials (including extended-spectrum cephalosporins), known as serotype Newport MDR-AmpC isolates, have been rapidly emerging as pathogens in both animals and humans throughout the United States. Resistance to extended-spectrum cephalosporins is associated with clinical failures, including death, in patients with systemic infections. In this study, 87<jats:italic>Salmonella</jats:italic>serotype Newport strains were characterized by pulsed-field gel electrophoresis (PFGE) and antimicrobial susceptibility testing and examined for the presence of class 1 integrons and<jats:italic>bla</jats:italic><jats:sub>CMY</jats:sub>genes. Thirty-five PFGE patterns were observed with<jats:italic>Xba</jats:italic>I, and three of these patterns were indistinguishable among isolates from humans and animals. Fifty-three (60%)<jats:italic>Salmonella</jats:italic>serotype Newport isolates were identified as serotype Newport MDR-AmpC, including 16 (53%) of 30 human isolates, 27 (93%) of 29 cattle isolates, 7 (70%) of 10 swine isolates, and 3 (30%) of 10 chicken isolates. However, 28 (32%)<jats:italic>Salmonella</jats:italic>serotype Newport isolates were susceptible to all 16 antimicrobials tested. The<jats:italic>bla</jats:italic><jats:sub>CMY</jats:sub>gene was present in all serotype Newport MDR-AmpC isolates. Furthermore, the plasmid-mediated<jats:italic>bla</jats:italic><jats:sub>CMY</jats:sub>gene was transferable via conjugation to an<jats:italic>Escherichia coli</jats:italic>strain. The transconjugant showed the MDR-AmpC resistance profile. Thirty-five (40%) of the isolates possessed class 1 integrons. Sequence analyses of the integrons showed that they contained<jats:italic>aadA</jats:italic>, which confers resistance to streptomycin, or<jats:italic>aadA</jats:italic>and<jats:italic>dhfr</jats:italic>, which confer resistance to trimethoprim-sulfamethoxazole. One integron from a swine isolate contained the<jats:italic>sat</jats:italic>-<jats:italic>1</jats:italic>gene, which encodes resistance to streptothricin, an antimicrobial agent that has never been approved for use in the United States. In conclusion,<jats:italic>Salmonella</jats:italic>serotype Newport MDR-AmpC was commonly identified among<jats:italic>Salmonella</jats:italic>serotype Newport isolates recovered from humans and food animals. These findings support the possibility of transmission of this organism to humans through the food chain.</jats:p>
収録刊行物
-
- Journal of Clinical Microbiology
-
Journal of Clinical Microbiology 41 (12), 5366-5371, 2003-12
American Society for Microbiology
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1363107369851794304
-
- NII論文ID
- 30021104780
-
- ISSN
- 1098660X
- 00951137
-
- データソース種別
-
- Crossref
- CiNii Articles